ImmuneHuman RCT
Thymosin alpha-1: what decades of human trials actually show
A licensed drug in some countries with thousands of trial patients behind it, but its biggest modern trials in sepsis and hepatitis C found no benefit.
Thymosin alpha-1
A 28-amino-acid thymus peptide sold as a drug in some countries; heavily trialled, but the largest modern trials in sepsis and hepatitis C were negative.
- Also known as
- Thymalfasin, Zadaxin, Tα1, Ta1
- Area
- Immune
- Status
- Approved in Italy and some Asian countries as Zadaxin; not approved in the UK or US